293 related articles for article (PubMed ID: 31131542)
1. Increased monocyte activation with age among HIV-infected long term non-progressor children: implications for early treatment initiation.
D'Souza RR; Gopalan BP; Rajnala N; Phetsouphanh C; Shet A
HIV Med; 2019 Sep; 20(8):513-522. PubMed ID: 31131542
[TBL] [Abstract][Full Text] [Related]
2. Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV.
Paul R; Apornpong T; Prasitsuebsai W; Puthanakit T; Saphonn V; Aurpibul L; Kosalaraksa P; Kanjanavanit S; Luesomboon W; Ngampiyaskul C; Suwanlerk T; Chettra K; Shearer WT; Valcour V; Ananworanich J; Kerr S
J Acquir Immune Defic Syndr; 2018 Apr; 77(4):417-426. PubMed ID: 29303843
[TBL] [Abstract][Full Text] [Related]
3. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.
Brusca RM; Hanna DB; Wada NI; Blankson JN; Witt MD; Jacobson LP; Kingsley L; Palella FJ; Budoff M; Brown TT; Anastos K; Lazar JM; Mack WJ; Bacchetti P; Tien PC; Golzar Y; Plankey M; Golub E; Kaplan RC; Post WS
HIV Med; 2020 Apr; 21(4):217-227. PubMed ID: 31729142
[TBL] [Abstract][Full Text] [Related]
4. High soluble CD163 levels correlate with disease progression and inflammation in Kenyan children with perinatal HIV-infection.
Generoso M; Álvarez P; Kravietz A; Mwamzuka M; Marshed F; Ahmed A; Khaitan A
AIDS; 2020 Jan; 34(1):33-38. PubMed ID: 31567161
[TBL] [Abstract][Full Text] [Related]
5. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
6. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
[TBL] [Abstract][Full Text] [Related]
7. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
8. Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.
Martin GE; Gouillou M; Hearps AC; Angelovich TA; Cheng AC; Lynch F; Cheng WJ; Paukovics G; Palmer CS; Novak RM; Jaworowski A; Landay AL; Crowe SM
PLoS One; 2013; 8(1):e55279. PubMed ID: 23365694
[TBL] [Abstract][Full Text] [Related]
9. Host Factor Predictors in Long-term Nonprogressors HIV-1 Infected with Distinct Viral Clades.
Dos Santos JS; de Almeida SM; Ferreira GS; Bordignon J; Maia Teixeira SL; Martins Lima AC; Raboni SM
Curr HIV Res; 2017; 15(6):440-447. PubMed ID: 29210660
[TBL] [Abstract][Full Text] [Related]
10. IL-8 Alterations in HIV-1 Infected Children With Disease Progression.
Pananghat AN; Aggarwal H; Prakash SS; Makhdoomi MA; Singh R; Lodha R; Ali S; Srinivas M; Das BK; Pandey RM; Kabra SK; Luthra K
Medicine (Baltimore); 2016 May; 95(21):e3734. PubMed ID: 27227934
[TBL] [Abstract][Full Text] [Related]
11. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
12. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
[TBL] [Abstract][Full Text] [Related]
13. Naïve CD4
Xu L; Liu Y; Song X; Li Y; Han Y; Zhu T; Cao W; Li T
BMC Immunol; 2021 Jun; 22(1):36. PubMed ID: 34082709
[TBL] [Abstract][Full Text] [Related]
14. Short Communication: SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort.
Williams B; Livak B; Bahk M; Keating SM; Adeyemi OM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):144-7. PubMed ID: 26366931
[TBL] [Abstract][Full Text] [Related]
15. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
[TBL] [Abstract][Full Text] [Related]
16. High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children.
Benki-Nugent SF; Martopullo I; Laboso T; Tamasha N; Wamalwa DC; Tapia K; Langat A; Maleche-Obimbo E; Marra CM; Bangirana P; Boivin MJ; John-Stewart GC
J Acquir Immune Defic Syndr; 2019 May; 81(1):102-109. PubMed ID: 30768490
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
[TBL] [Abstract][Full Text] [Related]
18. Reduced Natural Killer Cell Subsets in Perinatally Acquired Long-Term Non-Progressor Human Immunodeficiency Virus-Infected Children.
Bhukkar R; Sachdeva RK; Suri D; Shandilya J; Rawat A; Saikia B; Singh S
AIDS Res Hum Retroviruses; 2019 May; 35(5):437-443. PubMed ID: 30632379
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
[TBL] [Abstract][Full Text] [Related]
20. Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression.
Imp BM; Rubin LH; Tien PC; Plankey MW; Golub ET; French AL; Valcour VG
J Infect Dis; 2017 Jan; 215(1):114-121. PubMed ID: 27789726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
